The therapeutic potential of metabotropic glutamate receptor modulation for schizophrenia

Current Opinion in Pharmacology
Branden J Stansley, P J Conn

Abstract

Accumulating evidence suggests that a dysregulation of the glutamatergic system exists in the brains of schizophrenia patients. The metabotropic glutamate (mGlu) receptors are being investigated as novel drug targets for this disease, and have shown promise in both preclinical and clinical studies. Activation of mGlu5 receptors may be efficacious for several symptom domains (positive, negative, and cognitive) and the potential for targeting mGlu5 receptors has been bolstered by recent research on mitigating toxicity profiles associated with mGlu5 activation. Additionally, genetic profiling of schizophrenia patients suggests that genes encoding for mGlu1 and mGlu3 receptors are altered, prompting preclinical studies that have demonstrated potential antipsychotic and cognitive enhancing effects of agents that activate mGlu1 and mGlu3 receptors, respectively. Development of subtype-specific drugs for the mGlu receptors, such as allosteric modulators, could provide a path forward for more efficacious and tolerable therapeutics for schizophrenia.

Citations

Dec 6, 2019·Nature Communications·Chris H HabrianEhud Y Isacoff
May 26, 2020·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Réjane TroudetStéphane Jamain
May 9, 2019·Pharmacology Research & Perspectives·Tyler W McCullock, Paul J Kammermeier
Dec 20, 2018·Frontiers in Molecular Neuroscience·Francesco MatriscianoAlessandro Guidotti
Nov 17, 2020·Frontiers in Cell and Developmental Biology·Carolina GubertAnthony J Hannan
Apr 30, 2021·Frontiers in Neuroscience·Qiongqiong WuRenrong Wu
Jun 17, 2020·Current Drug Targets·Hemen S Ved, Gaurav M Doshi
Apr 8, 2020·ACS Pharmacology & Translational Science·Karen J GregoryColleen M Niswender
Aug 7, 2021·British Journal of Pharmacology·Caroline S CopelandThomas E Salt

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here